Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human APLP1 ELISA Kit (AC3122)
Cat.#: ASET-1711
Specifications
Description Human APLP1 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human APLP1 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.048 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 1.5-24 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1851 Human APC ELISA Kit (AC3262) Quantitative inquiry ASET-1747 Porcine Angiogenin ELISA Kit (AC3158) Quantitative inquiry ASET-2465 Human Syntaxin 1a ELISA Kit (AC3876) Quantitative inquiry ASET-2158 Human GDNF ELISA Kit (AC3569) Quantitative inquiry ASET-1415 Mouse nNOS (neuronal) ELISA Kit (AC2826) Quantitative inquiry ASET-1628 Human HAS3 ELISA Kit (AC3039) Quantitative inquiry ASET-1397 Human beta III Tubulin ELISA Kit (AC2808) Quantitative inquiry ASET-1235 Human Cadherin 10 ELISA Kit (AC2646) Quantitative inquiry ASET-1529 Human IL-6 ELISA Kit (AC2940) Quantitative inquiry ASET-2358 Human Glutamate Receptor 1 (AMPA subtype) ELISA Kit (AC3769) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket